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CLINICAL RELEVANCE 
 
Scientific rationale for the study: For augmenting soft tissue volume around dental 
implants, autogenous subepithelial connective tissue grafts (SCTGs) and a recently 
developed three-dimensionally stable collagen matrix (VCMX) showed similar results in 
augmented volume up to 3 months. Longer-term data for VCMX are not available so far.  
Principal findings: Between crown insertion and 1 year, the buccal soft tissue dimensions 
remained stable without relevant differences between sites that had previously been 
grafted with VCMX or SCTG. 
Practical implications: Once, final reconstructions were inserted and up to 1 year, peri-
implant soft tissues previously grafted with VCMX or SCTG remained stable.  
 
 
 
ABSTRACT 
 
Aim: To assess peri-implant soft tissue dimensions at implant sites, previously 
augmented with a collagen matrix (VCMX) or an autogenous subepithelial connective 
tissue graft (SCTG), between crown insertion and 1 year.  
Methods: Twenty patients with single-tooth implants received soft tissue augmentation 
prior to abutment connection randomly using VCMX or SCTG. Following abutment 
connection 3 months later, final reconstructions were fabricated and inserted (baseline). 
Patients were recalled at 6 months (6M) and at 1 year (FU-1). Measurements included: 
clinical data, soft tissue thickness, volumetric outcomes and patient-reported outcome 
measures (PROMs).  
Results: The buccal soft tissue thickness showed a median decrease of -0.5mm  
(-1.0;0.3) (VCMX) and 0.0mm (-0.5;1.0) (SCTG) (p=0.243) up to FU-1.  The soft tissue 
volume demonstrated a median decrease between BL and FU-1 of   
-0.1mm (-0.2;0.0) (p=0.301) for VCMX and a significant decrease of -0.2mm  
(-0.4:-0.1) (p=0.002) for SCTG respectively. Intergroup comparisons did not reveal any 
significant differences between the groups for peri-implant soft tissue dimensions and 
changes up to FU-1 (p>0.05). PROMs did not show any significant changes over time 
nor differences between the groups. 
Conclusion: Between crown insertion and 1 year, the buccal peri-implant soft tissue 
dimensions remained stable without relevant differences between sites that had 
previously been grafted with VCMX or SCTG.  
 
INTRODUCTION 
 
Peri-implant tissue health and stability over time are considered to be key factors in 
esthetic implant dentistry. Following tooth extraction, biological processes lead to a 
decrease in tissue volume, both, on the hard and soft tissue level (Araujo and Lindhe, 
2005). Apart from applying various approaches to minimize these changes in ridge 
dimensions using ridge preservation procedures (Jung et al., 2017),missing tissue 
volume is usually regenerated applying bone augmentation procedures and/or soft tissue 
augmentation (Schneider et al., 2011) (Buser et al., 1990) (Eghbali et al., 2016) 
More recently, clinical research focused on the relation between soft tissue quantity and 
quality and peri-implant tissue health. Based on systematic reviews and clinical studies, 
the soft tissue quality and quantity appear to play a crucial role in maintaining or 
improving peri-implant health over time (Akcali et al., 2016) (Gobbato et al., 2013).  
Various techniques and materials were described in the literature to augment soft tissue 
volume, with the autogenous subepithelial connective tissue graft (SCTG) being 
considered the gold standard (Bassetti et al., 2016),(Thoma et al., 2014).  
However, the use of autogenous soft tissue is associated with a number of disadvantages 
predominantly related to an increased patient morbidity and interindividual variations in 
terms of tissue quality and quantity that can be harvested (Burkhardt et al., 2015, 
Benninger et al., 2012). In order to overcome such limitations, a three-dimensionally 
stable collagen matrix (VCMX) was developed and subsequently evaluated in numerous 
preclinical and clinical studies, demonstrating favorable short-term results. (Thoma et al., 
2010, Thoma et al., 2016, Zeltner et al., 2017).  
While there is some evidence that pontic and implants sites, grafted with autogenous 
transplants maintain augmented tissue volume up to 10 years, similar data for soft tissue 
substitutes are lacking (Bienz et al., 2017b) 
The aim of the present clinical study was, therefore, to assess peri-implant tissue health, 
stability and volume changes at implants sites, previously augmented with VCMX or 
SCTG, from the insertion of single-tooth reconstructions  to 1 year.  
Materials and Methods 
 
Study design 
The present investigation was designed as a follow-up study of patients earlier enrolled in 
a randomized controlled clinical trial and performed in accordance with the ISO Standard 
14155:2011, Clinical Investigation of medical devices for human patients with the 
appendices VIII and X of the Medical Device Directive 93/42/EEC and with the 
Declaration of Helsinki, 2004 (Thoma et al., 2016). The study and its procedures were 
approved by the local ethics committee (KEK-ZH-Nr 2012-0226). The time-point 2 weeks 
following the insertion of the final reconstruction was considered as baseline (BL).  
 
The following inclusion criteria were applied at baseline (BL) for the present follow-up 
study: 
 
Inclusion criteria: 
1. Patients previously enrolled into the previous RCT (Thoma et al., 2016) comparing 
augmented soft tissue volume by the use of an SCGT or VCMX (Geistlich Fibro-Gide® 
Geistlich Pharma AG, Wolhusen, Switzerland)  
2. Final restoration inserted at implant site 
3. Ability to fully understand the nature of the proposed non- interventional long-term 
follow-up study and the ability to sign the informed consent form 
 
 
Exclusion criteria: 
1. Newly developed disease interfering with soft tissue regeneration (e.g. diabetes) 
2. Peri-implant infection (not related to previously performed soft tissue regeneration) 
following the insertion of the final reconstruction 
3. Second soft tissue augmentation since completion of study (Thoma et al., 2016) 
4. Severe trauma to implant site 
5. Orthodontic treatment in the same quadrant 
Clinical procedures 
 
All participants were previously enrolled into a randomized controlled clinical trial (Thoma 
et al., 2016). In brief, 20 patients with a soft tissue volume deficiency after the 
placement of a single tooth implant were randomly allocated to receive a soft tissue 
augmentation using VCMX or SCTG. Three months after soft tissue grafting, abutment 
connection was performed and final reconstructions fabricated and inserted. The present 
study was then designed as a non-interventional study following the insertion of final 
reconstructions (all screw-retained, single-tooth crowns). Two weeks after the insertion 
of final reconstructions, baseline measurements were performed (BL) and patients re-
examined at 6 months and 1 year.  
 
Outcome measures 
Assessment of soft tissue thickness  
The primary outcome was the change in soft tissue thickness from BL to 12 months. The 
thickness of the mucosa was measured with an endodontic instrument (RS STER K-File 
31/15, Dentsply Maillefer) 1mm apical of the margo mucosae at the mid-facial area of 
the implant-supported crown. 
 
Assessment of the volumetric changes  
 
At BL, 6 months (6M) and 1 year (FU-1), impressions of the implant sites were taken 
using an A-silicone impression material (Persident, Coltene /whaledent) including at least 
the two neighboring teeth and the respective mucosa. Dental stone casts were fabricated 
(Fujirock, Picodent) and optically scanned with a desktop 3D scanner (Imetric 3D, 
Courgenay, Switzerland). Subsequently, the obtained STL files were imported into a 
digital imaging software program (SMOP, Swissmeda, Zurich, Switzerland). A region of 
interest (ROI) was defined with a trapezoid shape. The ROI encompassed the following 
borders: 1mm apical of the margo mucosae (coronal), the mucogingival junction (apical), 
1mm distance from the neighboring tooth (mesial, distal). This ROI varied between 
patients, due to individual anatomical situations, but was kept constant in each patient 
and site over time. The images of the baseline and follow-up STLs were superimposed 
and matched using the best-fit algorithm at the adjacent tooth surfaces. The volumetric 
changes were calculated by the software measured in mm, which corresponded to the 
mean distance between the three surfaces representing the evaluated time-points (BL, 
6M and FU-1). 
Assessment of periodontal status 
At BL, 6M and FU-1, standard clinical and periodontal measurements were performed at 
the implant sites and the two neighboring teeth: the plaque index (PlI), the width of 
keratinized tissue (KT) at the buccal aspect, bleeding on probing (BOP) and probing 
depth (PD).  
Assessment of the soft tissue situation 
The Pink Esthetic Score (PES) (Furhauser et al., 2005) was recorded at BL, 6M and FU-1, 
evaluating the soft tissues around the implants encompassing 7 parameters and scores 
from 0 (poorest) to 2 (best). The highest achievable score was 14. 
 
Patient-reported outcome measures (PROMs) 
At BL, 6M and FU-1, an oral health impact profile questionnaire (OHIP-G14) was filled 
out by the patients.  
 
 
 
 
 
Statistical analysis  
Mean, median, standard deviation and the quartiles Q1 and Q3 were used to describe 
the continuously scaled variables (expressed as median (Q1;Q3) lateron) and counts 
and percentages for categorically scaled variables. Nonparametric statistical methods 
were applied. The differences of the medians between the treatment groups were 
evaluated with the Mann-Whitney and within a treatment group with the Wilcoxon 
signed rank test. The treatment related differences of medians are expressed as 
Hodges-Lehmann-estimates incl. the 95%-confidence intervals. 
The data were analyzed as intention-to-treat set (ITT: all randomized patients with post-
baseline data). No relevant differences were found between the results in both analysis 
sets. The results for the primary objective are therefore presented as PP analysis set 
(ITT analysis is not generally conservative in non-inferiority trials). 
As this was a follow-up investigation of a previous performed randomized controlled 
clinical trial, the sample size resulted out of the corresponding published study (Thoma 
et al., 2016) 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS 
All 20 patients originally included in the RCT entered the follow-up examination 
(baseline) between November 2012 and April 2015. Ten patients (mean age 44.1± 12.8 
years) had been treated with a VCMX (7 female, 3 male) and 10 patients (mean age 43.4 
± 18.8 years) with a SCTG (6 female, 4 male). A detailed description on patient 
demographics and augmentation sites is displayed in Tables 1A and 1B. No relevant 
differences regarding baseline periodontal parameters were observed between the two 
groups. One patient in group VCMX was lost to follow-up after the baseline examination 
due to emigration. The remaining 19 patients attended all follow-up appointments and 
data were included in the analyses.    
Soft tissue thickness  
The median thickness of the mucosa at baseline was 3.0mm (3.0;4.0) (VCMX) and 
3.0mm (2.5;3.0) (SCTG) (Hodges-Lehmann-estimation of difference: 0.5 [95%-CI: 
0.0;1.0], p=0.128). Median changes from BL to FU-1 were minimal in both groups 
resulting in a final mucosal thickness of 3.0mm (2.0;3.0) (VCMX) and 2.8mm (2.0;4.0) 
(SCTG) at FU-1 (Hodges-Lehmann-estimation of difference: 0.0 [95%-CI: -1.0;1.0], 
p=0.900). The changes between the different time-points were not statistically 
significantly different within (p=0.231; p=0.563) and in between the groups (p=0.243). 
All data are displayed in Table 2. 
Volumetric changes 
The descriptive data for the volume changes between BL, 6M and FU-1 are presented in 
Table 3. Changes between BL and FU-1 demonstrated a median non-significant decrease 
in soft tissue volume of -0.1mm (-0.2;0.0) for VCMX (p=0.301) and a significant 
decrease of -0.2mm (-0.4;-0.1) for SCTG respectively (p=0.002). No statistically 
significant differences were observed between the two groups for these changes 
(Hodges-Lehmann-estimation of difference: 0.1 [95%-CI: -0.1;0.4], p=0.369)(Fig 1A 
and 1B).  
Assessment of the soft tissue situation 
At BL, median PES scores were 9.0 (9.0;11.0) for VCMX and 8.5 (6.0;11.0) for SCTG 
(p=0.444). The respective PES scores at FU-1 were 9.0 (8.0;10.0) for VCMX and 9.0 
(7.0;11.0) for SCTG respectively (p=1.000). (Table 4) The PES score in the SCTG 
increased significantly up to 6 months with a median of 1.0 (0.0;3.0)(p=0.039) 
compared to a loss of -0.5 (-2.0;0.5)(p=0.406) for VCMX (intergroup comparison: 
p=0.031). From baseline to 1 year, PES scores remained stable in both group. The 
changes between the groups were not statistically significant (p=0.409). 
 
 
Periodontal outcome measures 
All implant sites demonstrated stable and healthy peri-implant tissues at BL, 6M and  
FU-1. No significant differences were observed between the groups for any of the 
outcome measures PlI, BOP and PD (p>0.05) (details see in Appendix Tables 1-3). 
At BL, the keratinized tissue at the buccal aspect of the implant showed a median width 
of 2.0mm (2.0;3.0) (VCMX) and of 3.0mm (2.0;4.0) (SCTG) (p=0.293).  
Both groups exhibited non-significant changes of the width of keratinized tissue over the 
observation time of 1 year (p=0.631), however resulting in a significant difference 
between the groups at 1 year (VCMX: 2.0mm (2.0;3.0); SCTG: 3.0mm (3.0;4.0) 
(p=0.037)) (Table 5). 
 
Patient-reported outcome measures (PROMs) 
Median overall OHIP scores were 0 at all time-points and in both groups (Table 6). 
 
 
 
 
 
 
Discussion 
 
The present non-interventional follow-up study demonstrated between the insertion of 
final reconstructions and one year of loading with single tooth reconstructions i) stable 
peri-implant soft tissue dimensions based on two- and three-dimensional analyses with 
minimal changes (<0.2mm) ii) healthy peri-implant tissues with minimal bleeding on 
probing and probing depth values; iii) stable esthetic outcomes based on PES scores in 
both groups. 
The peri-implant tissues of the 19 included patients and sites demonstrated, over the 
course of 1 year following loading with final reconstructions, only minimal changes based 
on a two-dimensional (soft tissue thickness) analysis. The three-dimensional (buccal 
volume) analysis showed a significant volume decrease at the buccal aspect of the 
implant sites both at 6 months and at 1 year of follow-up in the autogenous group 
(SCTG). Meanwhile, the volume remained stable in the VCMX group. Encompassing, 
however, the entire observation period, no relevant differences and changes were 
observed between the two groups. Scientific evidence assessing changes of peri-implant 
tissues following the insertion of final reconstructions is limited. In a prospective case 
series, 16 patients and sites were followed for one year after loading with final 
reconstructions. During that observation period, a labial volume loss of 0.04±0.31mm 
was recorded (Schneider et al., 2011). The present study showed a slightly higher 
median volume loss of 0.1mm for VCMX and 0.2mm for SCTG. The study revealed a 
heterogeneous pattern of volume changes with a slight loss in an area closer to the 
mucosal margin and a slight gain in a more apical area. A high variability between 
patients and sites was observed, what could also be observed in the present investigation 
with a standard deviation of 0.5mm (VCMX) and 0.2mm (SCTG) after 1 year.  
Longer-term data on volume changes of peri-implant tissues were reported by two 
recently published studies (Hanser and Khoury, 2016) (De Bruyckere et al., 2015).In a 
study reporting volume changes after implantation with a simultaneous connective tissue 
graft, 1 year after the insertion of the definitive implant-borne reconstructions, 50% of 
the reference points kept their volume from baseline to one year, whereas the other 50% 
showed a significant decrease (Hanser and Khoury, 2016). Another prospective case 
series analyzed implant sites in the esthetic zone receiving a SCTG 3 months after 
implant placement. Mean soft tissue loss after 1 year was 0.10± 0.23mm with no 
difference between patients with a thin or thick biotype (De Bruyckere et al., 2015). 
These results are in accordance with the results of the present investigation, even though 
both studies used a slightly different method to analyze the changes of the peri-implant 
tissues.  
More recently, the same method was used to evaluate volume changes of implant sites 
(Bienz et al., 2017a). Subepithelial connective tissue grafts were transplanted 3 months 
after implant placement. A median loss of -0.38mm was observed at the buccal aspect 5 
years after placement of the definitive reconstruction. In that study, however, abutment 
connection was performed 4-6 weeks after the soft tissue augmentation. Compared to 
the present study protocol, the earlier loading of the peri-implant soft tissues could have 
led to a slightly better tissue volume stability.  
Soft tissues undery changes beginning with the integration of the grafting material. Major 
changes can be expected up to the first 6 weeks after grafting (Studer et al., 
2000),(Rotenberg and Tatakis, 2014). In the present study, the insertion of the final 
reconstruction was considered as baseline. All patients were then followed-up for one 
more year. Therefore, soft tissue grafting procedures had been performed at least 4 
months earlier. Volume changes based on the initial grafting and healing period (3 
months) were reported previously (Thoma et al., 2016). One could therefore speculate 
that at the baseline time-point of the present non-interventional follow-up study, 
maturation of the augmented sites had already taken place.  This would then explain 
rather stable peri-implant contour dimensions between the insertion of the final 
reconstruction and the 1-year follow-up. 
Apart from more favorable esthetics, data in the literature are controversial in terms of 
potential benefits on the health of the peri-implant tissues following soft tissue grafting 
procedures. Studies have shown, though, that in case of implant sites with peri-implant 
disease, soft tissue grafting using SCTGs results in an improved peri-implant health 
(Schwarz et al., 2014a, Schwarz et al., 2015, Schwarz et al., 2014b). At implant sites 
with healthy peri-implant tissues, soft tissue grafting demonstrated to be beneficial with 
significantly less marginal bone loss (Thoma et al., 2017). In the present study, marginal 
bone level changes were not assessed, clinical indices for PD, PlI and BOP, however, 
were recorded. None of the assessed clinical parameters demonstrated any significant 
differences between the two groups, nor any significant changes over the 1-year 
observation period. These outcomes revealed that both treatment modalities rendered 
healthy peri-implant tissue.  
Achieving a favorable esthetic result is often a challenge for clinicians. Soft tissue 
grafting can be beneficial for implant sites regarding the esthetic result (Cornelini et al., 
2008, Rungcharassaeng et al., 2012). In order to assess the esthetic outcome of implant 
sites, numerous scoring systems and indices are available (Benic et al., 2012) (Cosyn et 
al., 2017) Among the most frequently used indices, is the so-called pink esthetic score 
(PES) (Furhauser et al., 2005). In the present study, both treatment groups achieved 
stable esthetic results based on median PES scores of 9.0 (VCMX) and 8.5 (SCGT) at 
baseline and 9.0 (VCMX) and 9.0 (SCTG) 1 year after loading. These results can also be 
explained by the case selection made in the present study. Every implant site was a 
single-tooth gap surrounded by natural teeth, presenting rather favorable conditions with 
the periodontium supporting the tissues of the adjacent implant. Moreover, the treatment 
protocol of the grafting procedure followed a delayed approach, at least 8 weeks after 
implant placement. In combination with a primary wound closure, the best possible blood 
supply was provided the grafts and the healing wound. Abutment connection was 
performed 3 months after the grafting, followed by the fabrication of the definitive 
implant-supported reconstruction. This protocol allowed for a further maturation of the 
peri-implant tissues before the insertion of the reconstruction, thereby explaining stable 
esthetic during the 1-year follow-up. 
 
 
 
Conclusion 
 
Between crown insertion and 1 year, the buccal peri-implant soft tissue dimensions at 
implant sites revealed only minimal changes without relevant differences between sites 
that had previously been grafted with VCMX or SCTG. Periodontal parameters remained 
stable over time and both treatment options resulted in esthetically stable results over 
the entire observation time.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table and figure legends 
 
Table 1A: Patient demographics and p-values (MWU-test). SD=standard deviation.  
Q1=25th percentile. Q3=75th percentile. VCMX=volume-stable collagen matrix. 
SCTG=subepithelial connective tissue grafts. 
Table 1B: Location and number of augmented sites for each group. VCMX=volume-stable 
collagen matrix. SCTG=subepithelial connective tissue grafts. 
Table 2: Soft tissue thickness and p-values (MWU-test) and change in soft tissue 
thickness and p-values (MWU-test). SD=standard deviation. Q1=first quartile. Q3=third 
quartile. Diff. [95%-CI] : Hodges-Lehmann-estimate of the treatment related difference 
incl. 95%-confidence interval. VCMX= volume-stable collagen matrix. 
SCTG=subepithelial connective tissue grafts. BL=baseline. 6M=Follow-up at 6 months. 
FU-1=Follow-up at 1 year 
Table 3: Change in soft tissue volume and p-values (MWU-test). SD=standard deviation. 
Q1=first quartile. Q3=third quartile. Diff. [95%-CI] : Hodges-Lehmann-estimate of the 
treatment related difference incl. 95%-confidence interval. BL=baseline. 6M=Follow-up 
at 6 months. FU-1=Follow-up at 1 year 
Table 4: Pink esthetic score and p-values (MWU-test) and change of pink esthetic score 
and p-values (MWU-test). SD=standard deviation. Q1=first quartile. Q3=third quartile. 
VCMX= volume-stable collagen matrix. SCTG=subepithelial connective tissue grafts. 
BL=baseline. 6M=Follow-up at 6 months. FU-1=Follow-up at 1 year 
Table 5: Width of keratinized tissue and p-values (MWU-test) and change of width of 
keratinized tissue and p-values (MWU-test). SD=standard deviation. Q1=first quartile. 
Q3=third quartile. VCMX= volume-stable collagen matrix. SCTG=subepithelial connective 
tissue grafts. BL=baseline. 6M=Follow-up at 6 months. FU-1=Follow-up at 1 year 
Table 6: OHIP-G14 score and p-values (MWU-test) SD=standard deviation. Q1=first 
quartile. Q3=third quartile. BL=baseline. 6M=Follow-up at 6 months. FU-1=Follow-up at 
1 year 
Figure 1A: A case of the VCMX –group: A) Clincal situation at baseline of the implant 
born reconstruction 21 B) Clinical situation at 1 year follow-up C) Cross-section through 
superimposed STL-Files. Green line=Baseline STL. Red line=Follow-up at 1 year STL. 
MG=Margo Gingivae. ROI=Region of interest. 
Figure 1B: A case of the SCTG–group: A) Clincal situation at baseline of the implant born 
reconstruction 12 B) Clinical situation at 1 year follow-up C) Cross-section through 
superimposed STL-Files. Green line=Baseline STL. Red line=Follow-up at 1 year STL. 
MG=Margo Gingivae. ROI=Region of interest. 
  
Appendix legends 
 
Appendix Table 1: Bleeding on probing and p-values (MWU-test) and change of bleeding 
on probing and p-values (MWU-test). SD=standard deviation. Q1=first quartile. Q3=third 
quartile. VCMX= volume-stable collagen matrix. SCTG=subepithelial connective tissue 
grafts. BL=baseline. 6M=Follow-up at 6 months. FU-1=Follow-up at 1 year 
Appendix Table 2: Plaque-Index and p-values (MWU-test) and change of Plaque-Index 
and p-values  (MWU-test). SD=standard deviation. Q1=first quartile. Q3=third quartile. 
VCMX= volume-stable collagen matrix. SCTG=subepithelial connective tissue grafts. 
BL=baseline. 6M=Follow-up at 6 months. FU-1=Follow-up at 1 year 
Appendix Table 3: Pocket depth and p-values (MWU-test) and change of Pocket depth 
and p-values  (MWU-test). SD=standard deviation. Q1=first quartile. Q3=third quartile. 
VCMX= volume-stable collagen matrix. SCTG=subepithelial connective tissue grafts. 
BL=baseline. 6M=Follow-up at 6 months. FU-1=Follow-up at 1 year 
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Table 1A 
 
 
 
  VCMX 
 
SCTG p-value 
Gender n (female) 7 6 p=1.000 
n (male) 3 4  
Age Mean ± SD 44.1 ± 12.8 43.4 ± 18.7 p=1.00 
 
 
Median 46.0 47.5 
Q1;Q3 39.0;48.0 23.0;60.0 
Cigarettes 
per day 
 
Mean ± SD  0.0 ± 0.0 1.0 ± 2.5 p=0.184 
Median 0.0 0.0 
Q1;Q3 0.0;0.0 0.0;0.0 
 
 
Table 1B  
 
 
Site 15 14 13 12 11 21 22 23 24 25 
VCMX 1    3 2   1 3 
SCTG    2 2 4 1    
 
Site 45 44 43 42 41 31 32 33 34 35 
VCMX           
SCTG      1     
 
Table 2  
 
  VCMX [mm] SCTG [mm] p-value 
BL 
n 9 10 
p=0.128 
Mean ± SD 3.2 ± 0.8 2.7 ± 0.4 
Median 3.0 3.0 
Q1;Q3 3.0;4.0 2.5;3.0 
Diff. [95%-
CI] 0.5 [0.1;1.1] 
6M 
N 8 10 
p=1.000 
Mean ± SD 2.9 ± 0.9 3.0 ± 0.9 
Median 3.0 3.0 
Q1;Q3 2.0;3.8 2.0;3.5 
Diff. [95%-
CI] 0.0 [-1.0;1.0] 
FU-1 
n 9 10 
p=0.900 
Mean ± SD 2.8 ± 0.7 3.1 ± 1.3 
Median 3.0 2.8 
Q1;Q3  2.0;3.0 2.0;4.0 
Diff. [95%-
CI] 0.0 [-1.0;1.0] 
BL to 6M 
n 8 10 
p=0.318 
Mean ± SD -0.3 ± 0.9 0.3 ± 1.0 
Median 0.0 0.0 
Q1;Q3 -0.5;0.0 0.0;1.0 
p (within 
grp) 
0.750 0.500 
Diff. [95%-
CI] 
-0.3 [-1.0;0.0] 
BL to FU-1 
n 8 10 
p=0.243 
Mean ± SD -0.4 ± 0.9 0.4 ± 1.4 
Median -0.5 0.0 
Q1;Q3 -1.0;0.3 -0.5;1.0 
p (within 
grp) 
0.231 0.563 
Diff. [95%-
CI] 
-0.5 [-2.0;0.5] 
 
 
 
 
Table 3 
 
  VCMX [mm] SCTG [mm] p-value  
BL to 6M 
n 9 10 
p=0.462 
Mean ± SD -0.1 ± 0.4 -0.2 ± 0.2 
Median 0.0 -0.1 
Q1;Q3 -0.2;0.1 -0.3;0.0 
p (within grp) 0.574 0.049 
Diff. [95%-CI] 0.1 [-0.2;0.3]  
BL to FU-1 
n 9 10 
p=0.369 
Mean ± SD -0.2 ± 0.5 -0.2 ± 0.2 
Median -0.1 -0.2 
Q1;Q3 -0.2;0.0 -0.4;-0.1 
p (within grp) 0.301 0.002 
Diff. [95%-CI] 0.1 [-0.1;0.4] 
 
 
 
Table 4 
 
  VCMX SCTG p-value 
BL  
n 10 10 
p=0.444 Mean ± SD 9.6  ± 1.6 8.4 ± 3.5 Median 9.0 8.5 
Q1;Q3 9.0;11.0 6.0;11.0 
6M  
n 8 10 
p=0.302 Mean ± SD 8.8 ± 1.8 9.8 ± 3.3 Median 9.0 10.0 
Q1;Q3 7.5;9.5 7.0;12.0 
FU-1  
n 9 10 
p=1.000 Mean ± SD 8.9 ± 2.4 9.1 ± 2.1 Median 9.0 9.0 
Q1;Q3 8.0;10.0 7.0;11.0 
BL to 6M 
n 8 10 
p=0.031 
Mean ± SD -0.6 ± 1.7 1.4 ± 1.6 
Median -0.5 1.0 
Q1;Q3 -2.0;0.5 0.0;3.0 
p (within grp) 0.406 0.039 
BL to FU-1 
n 9 10 
p=0.409 
Mean ± SD -0.4 ± 2.7 0.7 ± 1.9 
Median -1.0 1.0 
Q1;Q3 -2.0;2.0 -1.0;2.0 
p (within grp) 0.789 0.305 
 
 
 
 
  
Table 5 
 
  VCMX [mm] SCTG [mm] p-value 
BL 
n 10 10 
p=0.293 Mean ± SD 2.5 ± 0.8 3.2 ± 1.4 Median 2.0 3.0 
Q1;Q3 2.0;3.0 2.0;4.0 
6M 
n 9 10 
p=0.333 Mean ± SD 2.7 ± 1.2 3.1 ± 0.9 Median 2.5 3.0 
Q1;Q3 2.0;3.0 2.0;4.0 
FU-1 
n 9 10 
p=0.037 Mean ± SD 2.1 ± 1.2 3.2 ± 0.8 Median 2.0 3.0 
Q1;Q3 2.0;3.0 3.0;4.0 
BL to 6M 
n 9 10 
p=0.516 
Mean ± SD 0.3 ± 0.9 -0.1 ± 1.3 
Median 0.0 0.0 
Q1;Q3 0.0;1.0 0.0;0.0 
P (within grp) 0.406 1.000 
BL to FU-1 
n 9 10 
p=0.631 
Mean ± SD -0.2 ± 0.7 0.0 ± 1.2 
Median 0.0 0.0 
Q1;Q3 -1.0;0.0 -1.0;1.0 
P (within grp) 0.625 1.000 
 
 
 
 
 
Table 6 
 
  VCMX SCTG p-value 
BL  
n 10 10 p=0.624 
Mean ± SD 2.1  ± 5.0 0.6 ± 1.3 
Median 0.0 0.0 
Q1;Q3 0.0;1.0 0.0;1.0 
6M  
n 8 10 p=0.452 
Mean ± SD 1.3 ± 3.2 0.4 ± 1.3 
Median 0.0 0.0 
Q1;Q3 0.0 ;0.5 0.0;0.0 
FU-1 
n 9 10 p=0.520 
Mean ± SD 1.0 ± 2.6 0.5 ± 1.6 
Median 0.0 0.0 
Q1;Q3 0.0;0.0 0.0;0.0 
 
 
 
 
 
 
  
Figure 1a 
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